Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg 2+ homeostasis and cytoskeletal architecture

Simon Stritt, Paquita Nurden, Remi Favier, Marie Favier, Silvia Ferioli, Sanjeev K. Gotru, Judith M.M. Van Eeuwijk, Harald Schulze, Alan T. Nurden, Michele P. Lambert, Ernest Turro, Stephanie Burger-Stritt, Masayuki Matsushita, Lorenz Mittermeier, Paola Ballerini, Susanna Zierler, Michael A. Laffan, Vladimir Chubanov, Thomas Gudermann, Bernhard NieswandtAttila Braun

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Abstract

Mg2+ plays a vital role in platelet function, but despite implications for life-threatening conditions such as stroke or myocardial infarction, the mechanisms controlling [Mg2+] i in megakaryocytes (MKs) and platelets are largely unknown. Transient receptor potential melastatin-like 7 channel (TRPM7) is a ubiquitous, constitutively active cation channel with a cytosolic α-kinase domain that is critical for embryonic development and cell survival. Here we report that impaired channel function of TRPM7 in MKs causes macrothrombocytopenia in mice (Trpm7 fl/fl-Pf4Cre) and likely in several members of a human pedigree that, in addition, suffer from atrial fibrillation. The defect in platelet biogenesis is mainly caused by cytoskeletal alterations resulting in impaired proplatelet formation by Trpm7 fl/fl-Pf4Cre MKs, which is rescued by Mg2+ supplementation or chemical inhibition of non-muscle myosin IIA heavy chain activity. Collectively, our findings reveal that TRPM7 dysfunction may cause macrothrombocytopenia in humans and mice.

Original languageEnglish
Article number11097
JournalNature Communications
Volume7
DOIs
StatePublished - 29 Mar 2016
Externally publishedYes

Fingerprint

Dive into the research topics of 'Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg 2+ homeostasis and cytoskeletal architecture'. Together they form a unique fingerprint.

Cite this